Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Erfukang Chaji
- Development stage
- Unknown
- Lead developer
- Senkeyuan
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Erfukang Chaji (儿肤康搽剂), also known as Erfukang Topical Liniment, is a traditional Chinese medicine (TCM) topical formulation developed and manufactured by Sichuan Senke Pharmaceutical Co., Ltd. (associated with the brand Senkeyuan). The formulation is composed of 11 herbal ingredients: aloe (*Aloe vera*), *Sophora flavescens* (kushen), *Angelica dahurica* (baizhi), *Angelica sinensis* (danggui), *Dictamnus dasycarpus* (baixianpi), *Xanthium sibiricum* (cang'erzi), *Kochia scoparia* (difuzi), *Phellodendron* (huangbo), *Acorus tatarinowii* (shichangpu), *Artemisia argyi* (aiye), and *Gleditsia sinensis* (zaojiao). Indicated for the adjuvant treatment of pediatric dermatological conditions such as eczema, heat rash (prickly heat), and urticaria, it functions according to TCM principles to clear heat, eliminate dampness, and dispel wind to relieve itching. Pharmacologically, the formulation has been shown to inhibit histamine production and suppress delayed-type hypersensitivity reactions. It is approved in China for external application in children.
- Brand names
- 儿肤康搽剂Erfukang Chaji
- Other names
- Erfukang Topical LinimentErfukang Liniment
Beyond the preview
Go deeper on Erfukang Chaji.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Erfukang Chaji.